Prevail Therapeutics Inc. Contracts & Agreements
26 Contracts & Agreements
- Business Finance (5 contracts)
- Human Resources (8)
- Intellectual Property (2)
- Mergers & Acquisitions (1)
- Real Estate (1)
- Uncategorized (9)
- Agreement and Plan of Merger, dated as of December 14, 2020, by and among Prevail Therapeutics Inc., Eli Lilly and Company and Tyto Acquisition Corporation (pursuant to Item... (Filed With SEC on December 15, 2020)
- Tender and Support Agreement, dated December 14, 2020, by and among Eli Lilly and Company, Tyto Acquisition Corporation, OrbiMed Private Investments VI, LP (Filed With SEC on December 15, 2020)
- Tender and Support Agreement, dated December 14, 2020, by and among Eli Lilly and Company, Tyto Acquisition Corporation, Pontifax (Cayman) V L.P., Pontifax (China) V L.P.,... (Filed With SEC on December 15, 2020)
- Tender and Support Agreement, dated December 14, 2020, by and among Eli Lilly and Company, Tyto Acquisition Corporation and Asa Abeliovich, M.D., Ph.D (Filed With SEC on December 15, 2020)
- Form of Contingent Value Right Agreement, by and among Eli Lilly and Company, Tyto Acquisition Corporation and a rights agent mutually agreeable to Eli Lilly and Company and... (Filed With SEC on December 15, 2020)
- Open Market Sale AgreementSM dated as of August 11, 2020 by and between Prevail Therapeutics Inc. and Jefferies LLC (Filed With SEC on August 11, 2020)
- Description of Registrant's Securities (Filed With SEC on March 26, 2020)
- Form of Amended and Restated Employment Agreement between Registrant and Yong Dai, Ph.D (Filed With SEC on March 26, 2020)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 26, 2020)
- 2019 Equity Incentive Plan and forms of agreements thereunder (Filed With SEC on June 10, 2019)
- Form of Amended and Restated Employment Agreement between Registrant and Asa Abeliovich, M.D., Ph.D (Filed With SEC on June 10, 2019)
- Form of Amended and Restated Employment Agreement between Registrant and Jeffrey Sevigny, M.D (Filed With SEC on June 10, 2019)
- Form of Amended and Restated Employment Agreement between Registrant and Franz Hefti, Ph.D (Filed With SEC on June 10, 2019)
- Non-Employee Director Compensation Policy (Filed With SEC on June 10, 2019)
- 2019 Employee Stock Purchase Plan (Filed With SEC on June 10, 2019)
- Form of Underwriting Agreement (Filed With SEC on May 24, 2019)
- Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on May 24, 2019)
- Amended and Restated Investors Rights Agreement, dated March 19, 2019, by and among the Registrant and the investors party thereto (Filed With SEC on May 24, 2019)
- License Agreement, dated August 7, 2017, between the Registrant and REGENXBIO Inc., as amended (Filed With SEC on May 24, 2019)
- License Agreement, dated May 10, 2018, between the Registrant and REGENXBIO Inc (Filed With SEC on May 24, 2019)
- 2017 Equity Incentive Plan and forms of agreements thereunder (Filed With SEC on May 24, 2019)
- Form of Indemnity Agreement between Registrant and each of its directors and executive officers (Filed With SEC on May 24, 2019)
- Offer letter, dated September 15, 2017, between Registrant and Asa Abeliovich, M.D., Ph.D (Filed With SEC on May 24, 2019)
- Offer letter, dated March 1, 2018, between Registrant and Jeffrey Sevigny, M.D (Filed With SEC on May 24, 2019)
- Offer letter, dated February 26, 2018, between Registrant and Franz Hefti, Ph.D (Filed With SEC on May 24, 2019)
- Lease Agreement, dated September 29, 2017, between ARE-East River Science Park, LLC and the Registrant, as amended (Filed With SEC on May 24, 2019)
